-
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of NHGRI Participation in PAR-22-181, "Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Early Expiration of RFA-HG-21-041 "New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional)"
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of NCI's Participation in RFA-ES-23-007 "Exploratory Grants for Climate Change and Health Research Center Development (P20 Clinical Trial Optional)"
at National Institutes of Health in United States -
- Fellowship
- Posted 1 year ago
Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional)
at National Institutes of Health in United States -
- Fellowship
- Posted 1 year ago
Request for Information (RFI): Needs and Challenges in Obtaining and Testing Clinical-Grade RNA-based Cancer Vaccine Formulations to Support Translational and Clinical Research
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice to Expire RFA-RM-23-008 "Limited Competition: Molecular Transducers of Physical Activity Bioinformatics Center (U24 Clinical Trial Not Allowed)"
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice to Extend the Expiration Date of PAR-20-254: Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Correction to RFA-CA-22-050, NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01 Clinical Trial Optional)".
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Changes to the PAR-22-081, Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice to Expire RFA-RM-23-009 "Limited Competition: Molecular Transducers of Physical Activity Chemical Analysis Sites (U24 Clinical Trial Not Allowed)"
at National Institutes of Health in United States -
- Fellowship
- Posted 1 year ago
Notice of Special Interest (NOSI): Administrative Supplements for the Dog Oncology Grant Supplement (DOGS) Program
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice to Extend the Expiration Date of PAR-20-257: Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
at National Institutes of Health in United States -
- Fellowship
- Posted 1 year ago
Synthetic Nucleic Acid Platforms for HIV-1 (SNAPH): (R61/R33 Clinical Trial Not Allowed)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Participation of the National Institute on Aging (NIA) in PAR-22-181, "Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)"
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of NIAMS Withdrawal from PA-20-195 "Parent R21 Exploratory/Developmental Grant, Clinical Trial Not Allowed"
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice to Extend the Expiration Date of PAR-20-255: Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Change to Submission Requirements for PAR-22-184: Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Termination of RFA-TR-22-013 Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) Clinical Trial Not Allowed
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Special Interest: Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Informational Webinar for PAR-23-138 "Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed)"
at National Institutes of Health in United States -
- Fellowship
- Posted 1 year ago
Update to Policy and Procedures for the Reporting of Human Subjects Enrollment Data for NIA Clinical Research Trials/Studies
at National Institutes of Health in United States -
- Contract/Tender
- Posted 1 year ago
Notice of Special Interest (NOSI): RNA Modifications in Cancer Biology
at National Institutes of Health in United States -
- Contract/Tender
- Posted 1 year ago
Notice of Termination of RFA-TR-22-011 HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome (R21)
at National Institutes of Health in United States